ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

ROSEN, LEADING INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) […]

Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd

Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all

Shareholders who lost money on Sable Offshore Corp. (NYSE: SOC) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 26nd

(NYSE:SOC), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant

Toll Brothers Announces New Luxury Community Coming Soon to Milpitas, California

(NYSE:TOL), MILPITAS, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Toll Brothers at South Main, is coming soon to Milpitas, California. This exclusive all-electric community will feature new luxury townhomes designed to offer modern living spaces and high-end finishes. Sales

Shareholders who lost money on Sable Offshore Corp. (NYSE: SOC) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 26nd

Shareholders who lost money on Sable Offshore Corp. (NYSE: SOC) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 26nd GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces it has filed a class action lawsuit on behalf of purchasers of the

Toll Brothers Announces New Luxury Community Coming Soon to Milpitas, California

Toll Brothers Announces New Luxury Community Coming Soon to Milpitas, California GlobeNewswire August 04, 2025 MILPITAS, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Toll Brothers at South Main, is coming soon to Milpitas, California. This exclusive all-electric community will

Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending — Hagens Berman

(NYSE:LMT), SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. The lawsuit comes

Lockheed Martin (LMT) Faces Investor Scrutiny Over Company’s Disclosures About Aeronautics and RMS Segments’ Performance, Securities Class Action Pending — Hagens Berman

Lockheed Martin (LMT) Faces Investor Scrutiny Over Company's Disclosures About Aeronautics and RMS Segments' Performance, Securities Class Action Pending — Hagens Berman LMT Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 04, 2025 SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

(NASDAQ:REPL), SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NADAQ: REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes after

Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug – Hagens Berman

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug – Hagens Berman REPL Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 04, 2025 SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D.

Scroll to Top